Concepedia

Eran Blaugrund

EB

Statistics

Publications

17

Citations

1.2K

H-Index

15

Active since

1990

Affiliations

Teva Pharmaceuticals (Israel)(Current)

Weizmann Institute of Science

Tel Aviv University

Universität Ulm

Sorbonne Université

Eran Blaugrund is an author at Teva Pharmaceuticals (Israel) specializing in neuroscience, medicine, and pharmacology.

Publications per year

1990–2014

17

Publications

17

Guidelines for preclinical animal research in ALS/MND: A consensus meeting

Albert C. Ludolph, Caterina Bendotti, Eran Blaugrund et al. · Amyotrophic Lateral Sclerosis · 2010 · 314 citations · Full text

, , +16

Distinct subpopulations of enteric neuronal progenitors defined by time of development, sympathoadrenal lineage markers and <i>Mash-1</i>-dependence

Eran Blaugrund, Tuan D. Pham, Virginia M. Tennyson et al. · Development · 1996 · 227 citations

, , +12

Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: Report on the 142nd ENMC international workshop

Albert C. Ludolph, Caterina Bendotti, Eran Blaugrund et al. · Amyotrophic Lateral Sclerosis · 2007 · 112 citations

, , +17

Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation

Saleh Abu‐Raya, Eran Blaugrund, Victoria Trembovler et al. · Journal of Neuroscience Research · 1999 · 87 citations

, , +17

Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells

Saleh Abu‐Raya, Rinat Tabakman, Eran Blaugrund et al. · European Journal of Pharmacology · 2002 · 86 citations

, , +16

1–5 of 17